Chris Garabedian
North America, Massachusetts, United States, Boston
Description
Chris Garabedian founded Xontogeny in June of 2016 to support multiple promising technologies from early development through clinical proof ...
Investor Profile
Chris Garabedian has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 1 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B rounds (top funding stages).
- Majority of deals are located in United States.
- Strong thematic focus on Biopharma, Biotechnology, Clinical Trials.
Stage Focus
- Series B (100%)
Country Focus
- United States (100%)
Industry Focus
- Biopharma
- Biotechnology
- Clinical Trials
- Health Care
- Pharmaceutical
- Therapeutics
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
